NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/08/2026
Voltar para busca
Dado oficial do USPTO
ACTALLO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
16/10/2019
Data de registro
23/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2021
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
DAWE III, WILLIAM H
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Immatics Biotechnologies GmbH
Representantes
Anna Kurian Shaw Hogan Lovells US LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical and pharmaceutical productspharmaceutical preparations for the treatment of oncologicalanti-viralanti-bacterial and autoimmunity disorders and diseases and natural remedy preparations for the treatment of oncologicalviralbacterial and autoimmunity disorders and diseases; diagnostic reagents for medical purposes; synthetic peptidesbinding proteins and living cells for medicaldiagnostic and therapeutic purposesin particular for cancer therapy
Classe 42
Medical research and pharmacological research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistrybiochemistry and biology; scientific laboratory servicesbiologicalbiochemical and chemical laboratory services; biologicalbiochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory servicesbiological and biochemical laboratory services; biological and biochemical researchdevelopment and analysis services
Classe 44
Medical services and pharmaceutical servicesmedical diagnosis and medical diagnosis through the use of pharmacologicals of oncologicalviralbacterialautoimmune diseases; dispensing of pharmaceuticalsproviding medical supply for therapyin particular supply of synthetic peptidesbinding proteins and living cells for cancer therapy; medical diagnosis of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/06/2021
FIMP
FINAL DISPOSITION PROCESSED
29/06/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
10/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2021
PUBO
PUBLISHED FOR OPPOSITION
05/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/12/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/10/2020
GNRT
NON-FINAL ACTION E-MAILED
29/10/2020
CNRT
NON-FINAL ACTION WRITTEN
29/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2020
ALIE
ASSIGNED TO LIE
06/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/05/2020
RFNT
REFUSAL PROCESSED BY IB
21/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2020
RFRR
REFUSAL PROCESSED BY MPU
04/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
14/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/02/2020
CNRT
NON-FINAL ACTION WRITTEN
10/02/2020
DOCK
ASSIGNED TO EXAMINER
10/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACTALLO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.